Evidence map›Paper›PMID 41768043›Full record

ArticleEuropean urology open science2026

Complications and Risk Factors of Neurogenic Bladder: A Delphi Consensus.

Nicolas Turmel, Camille Chesnel, Pierre Denys, Xavier Game, Gérard Amarenco, Claire Hentzen

Abstract read
In one paragraph

Article in European urology open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicolas TurmelPublic Assistance Hospitals, Paris, France.
Camille ChesnelGRC-01 Group of Clinical Research in Neuro-Urology, Sorbonne University, Paris, France.
Pierre DenysDepartment of Rehabilitation Medicine and Pediatric Readaptation, Hospital Raymond-Poincare, Garches, France.
Xavier GameDepartment of Urology Andrology and Renal Transplantation, University Hospital Centre, Toulouse, France.
Gérard AmarencoGRC-01 Group of Clinical Research in Neuro-Urology, Sorbonne University, Paris, France.
Claire HentzenGRC-01 Group of Clinical Research in Neuro-Urology, Sorbonne University, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: Lower urinary tract symptoms secondary to neurogenic bladder impact quality of life and symptom burden significantly. These conditions are also associated with serious complications, including febrile urinary tract infections (UTIs) and impaired renal function. This study aimed to specify and rank the neurogenic bladder risk factors, their consequences, and finally the induced complications observed in neurourology. Methods: We conducted a Delphi consensus between October 2023 and April 2025. A steering committee performed a comprehensive literature review and drafted initial proposals. A review committee and a multidisciplinary expert panel were formed to evaluate and rate the proposals. The standard Delphi methodology was followed throughout. Key findings and limitations: After three rounds, 22 proposals were validated. Six proposals addressed the complications (renal failure, febrile UTIs, and autonomic dysreflexia), while 16 focused on risk factors, including disease modality (spinal cord injury and myelomeningocele), urodynamic characteristics (detrusor leak point pressure ≥40 cmH Conclusions and clinical implications: This consensus validated 22 expert-approved proposals, including six addressing the complications and 16 identifying the risk factors associated with neurogenic bladder. Patient summary: This expert's consensus provides a better understanding of upper urinary tract complications for patients with neurogenic bladder. It may help practitioners to better distinguish high-risk patients from low-risk patients and improve their management to avoid potential complications (renal failure, urinary tract infections, and other complications).

Indexed as

Delphi methodsNeurogenic bladderNeurourological risk

Identifiers

PMID41768043
PMCPMC12936485

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.